GATA6-AS is involved in endothelial–mesenchymal transition. Overexpression of lncRNA GATA6-AS inhibits cancer cell proliferation by downregulating GLUT1 and therefore inhibits glucose uptake in MCL. The gene discussed is SLC2A1; the disease is cancer.